Serum proteomics profiling - a young technology begins to mature

[11] Serum protein expression profiling for cancer detection: Validation of a SELDI-based approach for prostate cancer [J]. DISEASE MARKERS, 2003, 19 (4-5) : 185 - 195

[12] Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322

[13] Analysis of the low molecular weight fraction of serum by LC-dual ESI-FT-ICR mass spectrometry: Precision of retention time, mass, and ion abundance [J]. ANALYTICAL CHEMISTRY, 2004, 76 (17) : 5097 - 5103

[14] Diagnostic protein discovery using proteolytic peptide targeting and identification [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (21) : 2537 - 2548

[15] Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma [J]. MODERN PATHOLOGY, 2004, 17 (06) : 670 - 678

[16] Enhancement of sensitivity and resolution of surface-enhanced, laser desorption/lonization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques [J]. CLINICAL CHEMISTRY, 2005, 51 (01) : 65 - 74

[17] MORRIS JS, 2005, BIOINFORMATICS 0126

[18] Petricoin EF, 2002, J NATL CANCER I, V94, P1576

[19] Use of proteomic patterns in serum to identify ovarian cancer [J]. LANCET, 2002, 359 (9306) : 572 - 577

[20] Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma [J]. CANCER, 2004, 100 (09) : 1814 - 1822

[11] Serum protein expression profiling for cancer detection: Validation of a SELDI-based approach for prostate cancer [J]. DISEASE MARKERS, 2003, 19 (4-5) : 185 - 195

[12] Hu Jianhua, 2005, Briefings in Functional Genomics & Proteomics, V3, P322, DOI 10.1093/bfgp/3.4.322

[13] Analysis of the low molecular weight fraction of serum by LC-dual ESI-FT-ICR mass spectrometry: Precision of retention time, mass, and ion abundance [J]. ANALYTICAL CHEMISTRY, 2004, 76 (17) : 5097 - 5103

[14] Diagnostic protein discovery using proteolytic peptide targeting and identification [J]. RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2004, 18 (21) : 2537 - 2548

[15] Application of SELDI-TOF mass spectrometry for the identification of differentially expressed proteins in transformed follicular lymphoma [J]. MODERN PATHOLOGY, 2004, 17 (06) : 670 - 678

[16] Enhancement of sensitivity and resolution of surface-enhanced, laser desorption/lonization time-of-flight mass spectrometric records for serum peptides using time-series analysis techniques [J]. CLINICAL CHEMISTRY, 2005, 51 (01) : 65 - 74

[17] MORRIS JS, 2005, BIOINFORMATICS 0126

[18] Petricoin EF, 2002, J NATL CANCER I, V94, P1576

[19] Use of proteomic patterns in serum to identify ovarian cancer [J]. LANCET, 2002, 359 (9306) : 572 - 577

[20] Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma [J]. CANCER, 2004, 100 (09) : 1814 - 1822